TrialESC heart failure2024

Hydralazine combined with conventional therapy improved outcomes in severe systolic dysfunction and mitral regurgitation.

Shih-Hung Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.